Towards Healthcare
Human Growth Hormone Injection Market Trends and Companies

Human Growth Hormone Injection Market Growth and Industry Outlook

The human growth hormone injection market is growing as approval of this hormone for healthcare applications and extensive, controversial off-label applications for athletic improvement, weight loss, and anti-aging. North America is dominant in the market due to increasing research and development activities and the presence of sophisticated healthcare infrastructure.

Content

  • Last Updated: 27 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The human growth hormone injection market will surge by 2034, powered by technological advances and shifting consumer trends.

North America is currently leading the human growth hormone injection market share by 55% due to a rise in obesity rates.

Some key players include Pfizer Inc., Novo Nordisk A/S, F. Hoffmann-La Roche AG, Eli Lilly and Company, Sanofi S.A., and Teva Pharmaceutical Industries Ltd.

Growth hormone injections are most effective for increasing height when started early in childhood, before puberty, and when the growth plates close.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions